This course is designed to introduce some of the post-acute cancer treatment issues that are of paramount importance in the survivorship phase of cancer care.

NUMBER OF CREDIT HOURS: The Harvard Medical School designates this educational activity for a maximum of 2 AMA PRA Category 1 credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

COST: $40.00
click here for pricing outside the United States of America

OVERALL LEARNING OBJECTIVES:
After experiencing this course, participants will be able to:

1. Explain how exercise affects cancer survivors during and after primary treatment.
2. Address cognitive dysfunction and fatigue.
3. Diagnose new pain symptoms and treat appropriately.
4. Evaluate and treat lymphedema.

CLINICAL LEARNING OBJECTIVES:

1. Explain how exercise affects cancer survivors during and after primary treatment.
2. Address cognitive dysfunction and fatigue.
3. Diagnose new pain symptoms and treat appropriately.
4. Evaluate and treat lymphedema.

back to the top

JULIE SILVER, MD Course Director

Julie K. Silver, MD is an assistant professor in the Department of Physical Medicine and Rehabilitation at Harvard Medical School. Dr. Silver has expertise in oncology rehabilitation and founded a program called RESTORE to help cancer survivors physically recover from toxic treatments. Dr. Silver is an award-winning writer and has published more than twenty books that focus on helping people to physically recover from serious injuries and illnesses. She is the Chief Editor of Books at Harvard Health Publications (the consumer health branch of Harvard Medical School). She is the co-editor of one of the major textbooks in her medical specialty titled The Essentials of Physical Medicine and Rehabilitation (Elsevier). Library Journal named her trade book, After Cancer Treatment: Heal Faster, Better, Stronger (Johns Hopkins University Press) one of the top twenty health books released in 2006. Dr. Silver’s work in oncology rehabilitation was recognized by the American Cancer Society in 2006 when she was awarded the prestigious Lane Adams Quality of Life award. DISCLOSURE:

back to the top

ROBERT BROWN, MD Reviewer

Robert S. Brown, M.D. is the Clinical Chief of the Nephrology Division at Beth Israel Deaconess Medical Center (BIDMC) and the Joslin Diabetes Center. He is an Associate Professor of Medicine at Harvard Medical School. Dr. Brown received his A.B., magna cum laude, from Harvard College, his medical degree from Columbia College of Physicians & Surgeons where he was nominated to Alpha Omega Alpha Honor Medical Society. He trained in nephrology at the Yale New Haven Hospital. Dr. Brown is currently the Training Program Director in Nephrology, the Medical Director of the Medical Subspecialty Clinics, both at BIDMC, and a Co-Medical Director of two DaVita dialysis units. He has served as one of the original developers of the Firm System at BIDMC, serving as a Firm Chief for 12 years. He has written over 85 publications, including original research in hereditary renal cell carcinoma, metabolic electrolyte studies, clinical observations and clinical practice guidelines. He reviews publications or serves on the Editorial Board for multiple medical journals and has been a Principal Investigator in several multicenter clinical trials. He has served on multiple committees and/or the Board of Directors of several organizations, including the National Kidney Foundation, the National Kidney Foundation of Massachusetts, Rhode Island, New Hampshire, and Vermont, and the End-Stage Renal Disease Network of New England. Dr. Brown has received numerous honors, including the Outstanding Physician, Gift of Life Award, from the National Kidney Foundation of Massachusetts and Rhode Island, yearly listing as the Best Doctors of Boston Magazine, the Best Doctors in America, and he received the 2008 Parker J. Palmer "Courage to Teach" Award of the Accreditation Council for Graduate Medical Education. He is an invited lecturer in many national CME courses each year. DISCLOSURE:

MABEL CABAN, MD Reviewer

Bio and Photo Coming Soon. DISCLOSURE:

SUSAN PORIES, MD Reviewer

Dr. Susan Pories is an Assistant Professor of Surgery at Harvard Medical School. She is a breast cancer surgeon, surgical educator and scientific investigator. Her research focuses on biomarkers for the early detection of breast cancer. DISCLOSURE: Company: Predictive Biosciences Relationship: Consultant Content Area: Breast Cancer Company: Genomic Health Relationship: Speaker Content Area: Breast Cancer

ROBIN SCHOENTHALER, MD Reviewer

Dr. Schoenthaler has been a radiation oncologist with the Massachusetts General Hospital Department of Radiation Onocology and an Instructor at Harvard Medical School since 1992. She is a staff radiation oncologist at the MGH Dept of Radiation Oncology at Emerson Hospital in Concord, Massachusetts where her primary clinical emphasis is the treatment of women with breast cancer. She received her B.A. at the University of California at Berkeley, went to medical school at the University of California Los Angeles, and did a radiation oncology residency at the University of California at San Francisco. Following a fellowship in charged particles at Lawrence Berkeley Laboratory in Berkeley, California, Dr. Schoenthaler joined the faculty of MGH. She has been on the boards of numerous cancer-related organizations and is currently the Director of Medical Education at Emerson Hospital. She is also a writer of medical memoir, and has been published in the Boston Globe, Hospital Drive, Brain, Child, and other media. DISCLOSURE:

back to the top

NUMBER OF CREDITS: 2 

Harvard Medical School is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The Harvard Medical School designates this educational activity for a maximum of 2 AMA PRA Category 1 credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Upon completion of the course you will get a certificate via e-mail within 2 weeks.

Click the image to view a sample of the certificate

back to the top